6533b85cfe1ef96bd12bd4ef
RESEARCH PRODUCT
Hybrid supramolecular gels of Fmoc-F/halloysite nanotubes: Systems for sustained release of camptothecin
F. Di BlasiFrancesca D'annaCarla RizzoG. SpinelliGiuseppe LazzaraSerena RielaMarina MassaroFilippo ParisiRossella ArrigoNadka Tzankova Dintchevasubject
Materials scienceSupramolecular chemistryBiomedical EngineeringNanotechnology02 engineering and technologyengineering.material010402 general chemistry01 natural sciencesHalloysiteChemistry (all); Biomedical Engineering; Materials Science (all)HeLamedicineMoleculeGeneral Materials Sciencehalloysite supramolecular gel campthotecin drug delivery rheological propertiesSettore CHIM/02 - Chimica FisicabiologyChemistry (all)Settore CHIM/06 - Chimica OrganicaGeneral ChemistryGeneral Medicine021001 nanoscience & nanotechnologybiology.organism_classification0104 chemical sciencesSettore ING-IND/22 - Scienza E Tecnologia Dei MaterialiChemical engineeringSelf-healing hydrogelsengineeringMaterials Science (all)Nanocarriers0210 nano-technologyDrug carrierCamptothecinmedicine.drugdescription
Supramolecular gel hybrids obtained by self-assembly of Fmoc-L-phenylalanine (Fmoc-F) in the presence of functionalized halloysite nanotubes (f-HNT) were obtained in biocompatible solvents and employed as carriers for the delivery of camptothecin (CPT) molecules. The synthesis of the new f-HNT material as well as its characterization are described. The properties of the hybrid hydrogels and organogels were analyzed by several techniques. The presence of small amounts of f-HNT allows good dispersion of the tubes and the subsequent formation of homogeneous gels. The experimental results show that f-HNT functions only as an additive in the hybrid gels and does not demonstrate gelator behavior. The in vitro kinetic release from both f-HNT/CPT and Fmoc-F/f-HNT/CPT was studied in media that imitates physiological conditions, and the factors controlling the release process were determined and discussed. Furthermore, the antiproliferative in vitro activities of the gels were evaluated towards human cervical cancer HeLa cells. A comparison of data collected in both systems shows the synergistic action of f-HNT and the gel matrix in controlling the release of CPT in the media and maintaining the drug in its active form. Finally, a comparison with pristine HNT is also reported. This study suggests a suitable strategy to obtain two-component gel hybrids based on nanocarriers with controlled drug carrier capacity for biomedical applications.
year | journal | country | edition | language |
---|---|---|---|---|
2017-01-01 |